Cover Feature: Quinizarin Gold(I) N‐Heterocyclic Carbene Complexes with Synergistic Activity Against Anthracycline‐Resistant Leukaemia Cells: Synthesis and Biological Activity Studies (Chem. Eur. J. 11/2025)

The Cover Feature, created by Aditi Mulik from the Ruhr-Universität Bochum, illustrates a cellular tug-of-war between the design goals for cancer therapeutics of prioritizing selective targeting or increased cytotoxicity. In the associated Research Article (DOI: 10.1002/chem.202404147), N. Metzler-Nolte and co-workers explain how mitochondrial targeting allowed the less-cytotoxic compound to overcome resistance mechanisms and re-sensitized cancer cells to treatment.

Authors

Institutions

Publication Details

Journal
Chemistry - A European Journal
Published
2025-02-20
DOI
https://doi.org/10.1002/chem.202581104
Primary Topic
Quinazolinone synthesis and applications
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Cover Feature: Quinizarin Gold(I) N‐Heterocyclic Carbene Complexes with Synergistic Activity Against Anthracycline‐Resistant Leukaemia Cells: Synthesis and Biological Activity Studies (Chem. Eur. J. 11/2025)

Axel Steinbrueck, Aram Prokop, Axel Rosenhahn, Matthew L. Reback et al.
Chemistry - A European Journal
Quinazolinone synthesis and applications
article

Cover Feature: Quinizarin Gold(I) N‐Heterocyclic Carbene Complexes with Synergistic Activity Against Anthracycline‐Resistant Leukaemia Cells: Synthesis and Biological Activity Studies (Chem. Eur. J. 11/2025)

Axel Steinbrueck, Aram Prokop, Axel Rosenhahn, Matthew L. Reback, Christoph Rumancev, Daniel Siegmund, Jan Garrevoet, Nils Metzler‐Nolte, Gerald Falkenberg
article en

Abstract

The Cover Feature, created by Aditi Mulik from the Ruhr-Universität Bochum, illustrates a cellular tug-of-war between the design goals for cancer therapeutics of prioritizing selective targeting or increased cytotoxicity. In the associated Research Article (DOI: 10.1002/chem.202404147), N. Metzler-Nolte and co-workers explain how mitochondrial targeting allowed the less-cytotoxic compound to overcome resistance mechanisms and re-sensitized cancer cells to treatment.

Chemistry - A European JournalVol. 31(11)
Deutsches Elektronen-Synchrotron DESY (DE), MSH Medical School Hamburg – University of Applied Sciences and Medical University (DE), Fraunhofer Institute for Environmental, Safety and Energy Technology UMSICHT (DE), Helios Hospital Schwerin (DE), Ruhr University Bochum (DE)
Openalex Percentile: Top 98%
Quinazolinone synthesis and applications
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.